Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. 

Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery.
We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications.

Explore our website to learn more www.ncardia.com.


Biotechnology

Life Sciences

Pharmaceutical

Therapeutics

Ncardia

Gustavo Mahler

Shushant Jain

Elodie Noël

Rosa García-Verdugo

Timothy Keefe

Dominique Vanfleteren

Charles Jacques

Stefan Braam

The Leadership Team at Ncardia is responsible for steering the company's strategic direction, ensuring operational excellence, and driving business growth. Comprising senior executives, including the CEO, COO, and CFO, this team provides organizational oversight, sets scientific and innovation strategies, and fosters strategic partnerships. They work collaboratively to maintain Ncardia's position as a leader in iPSC technology and drug discovery, while addressing customer needs and ensuring financial stability and regulatory compliance.

Leadership Team

Scientific Team

Directors Team

Leadership Team

About

Team members

Other teams at Ncardia

Scientific Team

Directors Team